Introduction
============

Matrix vesicles (MVs) are extracellular membrane invested entities, about 100 nm in size, located in the matrix of bone, cartilage and dentin ([@B1]). They serve as the initial site of calcification in all skeletal tissues. The mechanism of MV-mediated mineralization is biphasic. In Phase-I, MVs initiate mineralization through the action of MV-associated phosphatases and calcium-binding phospholipids and proteins ([@B1]). MV phosphatases, including alkaline phosphatase (ALP), ATPase, 5'-AMPase, and nucleoside triphosphate pyrophosphohydrolase (NTPPPH), play an active role in initiating MV mineralization ([@B2]). Phosphoester substrates such as ATP, AMP and PPi are hydrolyzed by MV phosphatases, thereby increasing the local concentration of orthophosphate and thus initiating mineralization ([@B2]). In Phase-II, the mineral formed inside the MVs penetrates the vesicular membrane and in the presence of physiological concentrations of extravesicular Ca^2+^, PO4^3-^, and pyrophosphate (PPi), the MV-initiated calcium phosphate mineral serves as nuclei for the formation of stellate clusters of needle-shaped biological apatite ([@B1]). In the presence of physiological extracellular concentrations of Ca^2+^and PO4^3-^, crystal propagation occurs. Calcifiable MVs can be isolated from collagenase-digested growth plates, and are generated by rat or chick chondrocytes or Saos-2 osteoblastic cells in culture ([@B3]-[@B11]). Ultra-structural examination of matrix vesicles of growth plate cartilage or primary chondrocyte cultures have demonstrated the presence of mineral in these vesicles which morphologically resembles apatite of calcified cartilage and bone (Fig. [1](#F1){ref-type="fig"}). MV-mediated *in vitro* calcification has been more routinely demonstrated by measuring radioactive calcium (^45^Calcium) deposition by isolated MVs. In this report, we describe a sensitive technique for studying *in vitro* calcification of isolated matrix vesicles using a non-radioactive calcium-*O*-cresolpthalein complexone (*O*-CPC) binding assay.

![Electron micrograph of mineralizing matrix vesicles showing radial clusters of hydroxyapatite like mineral (X 110,000).\
The dark arrows show needle shaped hydroxyapatite mineral while the grey arrow shows intact MV. MVs isolated from growth plates of rachitic rats were calcified upon exposure to calcifying buffer containing physiological concentrations of Ca^2+^ and Pi. The calcified MVs were fixed in 2.5% glutaraldehyde, post fixed in 1% osmium tetraoxide, dehydrated, embedded in Spurr\'s low viscosity epoxy resin. Thin sections were cut and stained with uranyl acetate and lead citrate, and photographed using a Zeiss EM IOA electron microscope.](bpo_v6_p263_m97f1lg){#F1}

This assay is based on the following principle:

This assay, based on the micro-method of calcium determination using *O*-cresolpthalein complexone dye ([@B12]), involves the reaction of calcium with *O-*CPC to produce a purple complex at pH 10-12 with an absorbance maximum at 575 ± 5 nm. The intensity of the color is directly proportional to the concentration of calcium in the sample. This colorimetric assay has been previously used in cell cultures for determination of calcium ([@B13], [@B14])**.**This assay has also been used to determine calcium from trichloroacetic acid-extracted bone samples ([@B15], [@B16]). Here, in this paper we describe a novel application of this technique in studying MV-mediated calcification. The advantage of this colorimetric technique for studying MV-mediated non-radioactive *in vitro* calcification over the conventional ^45^Ca radioactive procedure lies in its simple, direct, sensitive, highly specific and readily adaptable nature. This assay is linear from 0.1-5mM calcium concentration. There are very few non-radioactive methods that have been applied for determining calcium from mineralized matrix vesicles. Kirsch *et al*. ([@B17]) have used a fluorometric procedure for measuring Ca^2+^ uptake by matrix vesicles. This procedure is based on the determination of calcium by calculating the difference in fluorescence intensity of calcium bound Fura-2 in triton-lysed samples of matrix vesicles that were incubated for 24 h in synthetic cartilage lymph vs. fluorescence intensity of Fura-2 bound calcium in triton-lysed samples of freshly isolated, non-incubated matrix vesicles (control). Other researchers such as Wu *et al*. ([@B18]) have used Baginski's procedure ([@B19]) for calcium analysis from acid extracted samples of calcified matrix vesicles.

Materials and Methods
=====================

**Induction of rickets**
------------------------

Rickets was induced in male weanling Sprague Dawley rats by housing weanling rats in a dark room and feeding them a diet low in phosphorous and Vitamin D ([@B20]). After 4 weeks on rachitogenic diet, the rats were sacrificed according to the guidelines of the Institutional Animal Care and Use Committee (University of Kansas Medical Center), and their hypomineralized tibial and femoral growth plate were dissected for further isolation of chondrocytes and MVs. The rationale for using rachitic rat growth plate is that it provides an ideal model for studying MV initiated *in vitro* calcification without complication from propagation of pre-existing mineral.

**Isolation of MVs from rachitic rat growth plates**
----------------------------------------------------

![Flow diagram showing the isolation of rat growth plate matrix vesicles (as described in (3) and (21)).](bpo_v6_p263_m97f2lg){#F2}

MVs were isolated from rachitic rat growth plates by collagenase digestion as described previously ([@B21]). The isolation of matrix vesicles from rat growth plates is shown as a flow chart in Figure [2](#F2){ref-type="fig"}. Briefly, epiphyseal growth plates from 30 rats were dissected and finely minced. The minced tissue was then digested in a collagenase digestion mixture containing 0.45% collagenase (Boehringer Mannheim), 0.12 M NaCl, 0.01 M KCl, 1000 units/ml of penicillin, 1 mg/ml of streptomycin, and 0.05 M Tris buffer (pH 7.6 at 37°C). Collagenase digestion was done at 37°C for 3h. The collagenase digest was then centrifuged at 1100g for 10 min to harvest cells. This pellet was used for *in vitro* culture of chondrocytes ([@B4]-[@B7]). The supernatant was subjected to a two-step differential ultra-centrifugation for the isolation of MVs. The first step involves the centrifugation of collagenase digest at 30,000X g for 10 min to remove nuclei, mitochondria, lysosomes and smaller cell fragments. The supernatant was then further centrifuged at 280,000X g for 45 min. to obtain a highly pure MV pellet. The yield of MVs was estimated by measuring the protein content by Bradford assay (Biorad) and alkaline phosphatase specific activity of the micro-vesicle fractions released from collagenase-digested growth plates (Alkaline phosphatase specific activity by Sigma Diagnostic Kit-104LS). Briefly, a small volume of MV suspension was added to the ALP assay mixture containing p-nitrophenyl phosphate as substrate in 750 mM 2 amino, 2 methyl, 1-propanol (pH 10.25) and 4 mM MgCl~2~. The absorbance of nitrophenol, a chromogenic product produced in the presence of ALP, was measured with a plate reader (Multiskan Plus; Fisher Scientific) at 405 nm (Millimolar absorbtivity of p-nitrophenol at 405 nm is 18.45M^-1^cm^-1^).

**In vitro calcifiability of MVs**
----------------------------------

Calcifiability of MVs isolated directly from growth plates (native) was assessed by non-radioactive calcium phosphate deposition assay. Briefly, this assay involves the incubation of 30 μg samples of MV protein in a calcifying solution containing 2.2 mM Ca^2+^ and 1.6 mM PO4^3-^ in the presence of 0 to 3 mM phosphoester substrate, for example, ATP, AMP or β-GP in 0.05M Tris buffer (pH 7.6 at 37°C) for 5.5 h at 37°C. The incubation was terminated after 5.5 h by centrifugation at 8800g for 30 min. to co-precipitate MVs and calcium phosphate mineral formed during incubation. The pellet containing calcium phosphate mineral was then solubilized with 0.6N HCl for 24 h. The calcium content of the HCl supernatant was then determined colorimetrically by the *O*-cresolpthalein complexone method (Calcium Kit, Procedure no. 587, Sigma-Aldrich Corporation, St. Louis, MO and Procedure No. 0150, Stanbio Laboratory, Boerne, TX). Briefly, 2 μl of acidified supernatant was incubated with 200 μl of calcium working reagent (Color Reagent + Base Reagent Mix) for 1 minute for microplate reader or 10 μl of acidified supernatant with 1ml of calcium working reagent for UV-VIS spectrophotometer. The absorbance of calcium standard and calcium were read against blank at 570 nm within 60 minutes.

The standard curve of the assay is shown Figure [3](#F3){ref-type="fig"}. Protein content was measured using Bradford protein assay kit (BioRad). Samples were calibrated against a calcium standard (10mg/dl, Calcium kit, Sigma and Procedure No. 0150, Stanbio Laboratory), and absorption was measured at 575 ± 5 nm using a spectrophotometer or microplate reader.

![Standard curve for o-cresolopthalein complexone assay.](bpo_v6_p263_m97f3lg){#F3}

**Statistical analysis**
------------------------

Quantitative data are presented as mean ± S.D. Statistical significance between groups was determined by analysis of variance (ANOVA) and paired t- test.

Results and Discussion
======================

We report here, a non-radioactive technique for studying MV-mediated *in vitro*calcification. *O*-CPC assay was demonstrated here to be a convenient, sensitive and extremely relevant analytical method to study mineral initiation and mineral propagation by MVs. Using this assay, we report here that collagenase-released MVs from rachitic rat growth plates were able to deposit when exposed to calcifying buffer containing physiological concentrations of calcium and phosphate ions (Fig. [4](#F4){ref-type="fig"}).

![Comparison of in vitro calcification profile of isolated MVs in the presence of 1mM ATP, 3mM AMP and 3 mM β-GP using O-CPC assay.\
The calcium concentration is first obtained for each of the samples using calcium standard. The relative values are used to compare changes in the calcium deposition ability relative to the control reference sample (MVs in the absence of phosphoester substrates). Values are expressed as means ± S.D. from five different MV preparations. Double asterisks are assigned to indicate the statistical significance (P\<0.05) with respect to control. Single asterisks are assigned to indicate the statistical significance (P\<0.05) between groups (MV+ATP vs. MV+AMP, and MV+ATP vs. MV+ β-GP).](bpo_v6_p263_m97f4lg){#F4}

Furthermore, we also show that AMP or β-GP (i.e. monophosphoester substrates for ALP and AMPase) were more effective in promoting calcium deposition by isolated MVs than ATP based on a comparable amount of phosphatase-releasable ester phosphate per one mole of ATP versus three moles of AMP or β-GP (Fig. [4](#F4){ref-type="fig"}). Our finding that monophosphoesters are better substrates of mineralization is consistent with the several reports on the role of β-GP in stimulating mineralization in osteoblast or chondrocyte *in vitro* cell cultures ([@B22]-[@B26]). This finding also draws further support from a kinetic study that demonstrated AMP and β-GP to be better substrates of alkaline phosphatase activity than ATP or ADP (Vmax values of β-GP was 76%, AMP was 62% and ATP was 15% relative to p-nitrophenylphosphate) ([@B27]). The finding that AMP and not ATP was present in high concentration in the mineralized regions of freeze-trapped endochondral cartilage of chick ([@B28]), further supports our results. Electron microscopic and X-ray diffraction studies on isolated MVs, calcified *in vitro* in the presence of AMP reveal the formation of hydroxyapatite crystals ([@B29]). Futhermore, only amorphous calcium pyrophosphate mineral was deposited by isolated human osteoarthritic MVs and rachitic rat MVs in the presence of ATP in mineralization assays ([@B30], [@B31]). The mechanism of enhanced mineralization by monophosphoesters such as AMP and β-GP is believed to be mediated by (a) increasing the local concentration of Pi ([@B22]-[@B24]) and (b) inhibiting the activity of NTPPPH ([@B23], [@B32]). One possible reason for monophosphoesters being better substrates for MV-mineralization than ATP might be due to the generation of PPi during the hydrolysis of ATP by NTPPPH. PPi at concentrations higher than 1mM can inhibit mineralization ([@B33]).

![Schematic diagram showing the metabolism of ATP and AMP and the effect of products of their hydrolysis on mineralization.\
ATP is hydrolyzed by nucleoside triphosphate pyrophosphohydrolase (NTPPPH) to AMP and inorganic pyrophosphate (PPi), which get further degraded to yield inorganic phosphate (Pi) by alkaline phosphatase (ALP). The inorganic phosphate thus generated forms apatite in the presence of calcium of the extracellular fluid. Accumulation of excess PPi results, in the inhibition of apatite deposition.](bpo_v6_p263_m97f5lg){#F5}

Excess accumulation of PPi prevents the transformation of amorphous calcium phosphate to hydroxyapatite ([@B34]-[@B36]). Thus, the steady state concentration of PPi, maintained by concerted activities of NTPPPH and ALP (Fig. [5](#F5){ref-type="fig"}) regulates the formation and propagation of mature mineral. AMP, also formed during the hydrolysis of ATP by NTPPPH activity, is further metabolized to adenosine and Pi by 5' AMPase or ALPase. The mineral formed when isolated MVs were exposed to calcifying buffer containing AMP was identified as crystalline hydroxyapatite by Fourier transform infrared spectroscopy (data not shown).

Conclusions
===========

The non-radioactive *O*-CPC assay to study *in vitro* calcium deposition by isolated MVs, is simple and highly sensitive, and can offer a useful alternative approach to the routinely used radiometric biomineralization assay which employs radioactive ^45^Ca. Application of this technique for studying *in vitro* non-radioactive calcium deposition by isolated MVs, demonstrates that monophosphoesters such as AMP and β-GP are better substrates of mineralization than ATP.
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